Skip to main content

Medical Cannabis Safe Access To Expand In Israel

When it comes to medical cannabis research, Israel has long served as an international leader. After all, it is where International Cannabis Business Conference speaker alumni Raphael Mechoulam became the first person in history to isolate tetrahydrocannabinol (THC), in addition to numerous other cannabis research breakthroughs.

Unfortunately, general medical cannabis policy and safe access for domestic patients have never seemed to receive the same level of embrace and consideration in Israel for some reason, with many patients reporting gaps in being able to acquire their medicine.

Israel currently serves as the top importer of medical cannabis products, which doesn’t make a lot of sense since the country obviously knows how to harness the cannabis plant and maximize its potential. The only logical explanation is that the nation’s laws are holding the domestic medical cannabis sector back.

Thankfully, there appear to be meaningful changes on the way, with it being reported that Israeli medical cannabis patients will soon no longer be required to obtain a special license for medical cannabis, per a recently approved reform measure. Per YNetNews:

The Knesset’s Health Committee decided on Tuesday that access to medical cannabis will be significantly expanded, with many more patients qualifying – without the need to obtain a special license to use the drug.

The decision is part of a reform led by the Health Ministry in recent months. Within the reform’s framework, patients with a wide range of diseases and medical conditions will no longer be required to obtain a license in order to receive medical cannabis.

The reduced hurdles for obtaining medical cannabis are surely welcomed. With that being said, medical cannabis patients in Israel still are at the mercy of whatever supply they can access. As more patients presumably enter the medical cannabis sector as a result of the change, it will need to be met with boosts in domestic supply.

As is the case with any country, the only real way to ensure that every patient has safe access to medical cannabis is to legalize it for adult use, in addition to medical cannabis policies, and to afford every patient the right to cultivate their own medicine and/or join a noncommercial cannabis club.

French Town Wants To Launch Cannabis Pilot Program

By many measures, the concept of a cannabis commerce pilot program is a relatively new thing. While they are already in existence in Europe, it is only in recent years that they seem to have entered the mainstream policy reform conversation on the continent.

Switzerland has embraced the cannabis commerce pilot program more than any other nation so far. A cannabis commerce pilot program involves a jurisdiction being permitted to allow limited cannabis sales as part of ongoing government social science research.

In theory, by allowing limited cannabis sales, data can be collected, and the analysis of that local data can then help lawmakers and regulators be better suited to craft national cannabis policies. Cannabis commerce pilot programs have their limitations to be sure, however, for participants, it effectively results in legalized cannabis and the freedoms that go with it. Additionally, the concept is EU-approved and does not run afoul of EU agreements (unlike national legalization).

France has historically moved much slower on cannabis reform compared to some of its European counterparts, but if one small town has its way, it will launch its own cannabis commerce pilot program sooner rather than later. Per Newsweed:

The mayor of Bègles, a small town of 30,000 inhabitants close to Bordeaux, wants to make his city a territory for experimenting with the supervised legalization of cannabis.

Mayor Clément Rossignol Puech’s proposal to experiment with the production, sale and consumption of cannabis in Bègles has its origins in two recent reports: one from the Information Mission on the Uses of Cannabis, held to the National Assembly in 2021, and the other to the Economic, Social and Environmental Council (CESE) in 2023. These two reports came out in favor of a supervised legalization of cannabis.

While it is never easy to guarantee anything in the cannabis world, it does seem in increasing fashion that the cannabis commerce pilot program model is here to stay in Europe. Pilot programs are the focus of ‘phase 2’ of legalization in Germany according to the current plan, and pilot discussions in other countries appear to be heating up as well.

Pilot programs are clearly not as good as national legalization, such as what is found in Canada. However, when coupled with noncommercial clubs and home cultivation, such as what is being proposed in Germany, it can provide a significant amount of freedom to cannabis consumers. Hopefully other lawmakers join Mayor Clément Rossignol Puech’s push for pilot programs in France.

What Is Next For The Cannabis Industry?

The emerging legal cannabis industry is continuing to undergo a dramatic evolution, particularly in Europe. The momentum for global reform is greater now than at any other time since the dawn of prohibition, and the biggest domino to date is teetering and getting closer to toppling with every passing day. That domino is, of course, Germany.

Cannabis advocates have fought for reform in Germany for many years, however, the legalization effort picked up considerable steam in mid-2021 when the results of the federal election that year yielded a governing coalition that quickly expressed its desire to modernize Europe’s cannabis policies.

Germany was already home to the largest legal medical cannabis industry in Europe at the time, and initially, it seemed that Germany would launch legal national adult-use cannabis sales in a quick fashion. Then, for over a year, German Health Minister Karl Lauterbach worked behind the scenes, with details of his legalization plan leaking every once in a while.

Eventually, Minister Lauterbach held a press conference in October 2022 to announce some of the provisions he would be seeking but made it abundantly clear that his next stop was the European Union to try to get its permission to proceed.

Unfortunately, the effort hit some turbulence once Germany’s Health Minister started negotiating with the European Union, with Minister Lauterbach providing an update in April 2023 in which he indicated that the European Union would allow parts of the previously outlined legalization plan to proceed and prohibit other parts.

The main component that the European Union stated it would not permit was nationwide adult-use cannabis sales to anyone of legal age. The blocking of that robust provision seemed to send many newer industry members into a bit of a spiral. The fact of the matter is that cannabis reform rarely, if ever, follows a linear path. It is full of twists and turns, and Germany is the latest example of that.

With those twists and turns comes opportunity, as not everyone is able to navigate the shifting landscape. People who are able to navigate the shifting landscape, that can identify trends, and maximize windows of opportunity, will reap significant rewards.

What legalization will ultimately look like in Germany once it is finally implemented is something that we will have to wait and see, however, the basic provisions are already known – personal cultivation, possession, and consumption will be legal and noncommercial clubs will be permitted.

Eventually, regional adult-use commerce pilot programs will launch as well. All of that creates opportunities for entrepreneurs, investors, and industry service providers if they know what to anticipate and where to focus on developing innovative ideas.

The best way to learn what is next for the emerging cannabis industry, both in Germany and beyond, is to hear from true international cannabis experts that spend every day on the frontlines of cannabis reform and industry. Fortunately, the upcoming International Cannabis Business Conference in Berlin, Germany later this month provides that exact opportunity.

Following yet another successful cannabis super-event in Barcelona, the International Cannabis Business Conference is once again bringing its flagship B2B event and tradeshow back to Berlin, Germany on June 29th-30th, 2023. In addition to the B2B event, which is the largest of its type in Europe, the International Cannabis Business Conference will also hold a Global Investment Forum in Berlin on June 27th.

Both events will feature leading cannabis industry experts, and the B2B event has a panel specifically dedicated to discussing what is next for the international cannabis industry now that the curtain dropped in Germany. The panel will feature:

Over 5,000 cannabis leaders from over 80 countries will be represented at the International Cannabis Business Conference in Berlin and that includes representatives from every sector of the industry as well as leading international cannabis policymakers and industry service providers.

Attend the International Cannabis Business Conference in Berlin to network with investors, entrepreneurs, industry regulators, and international policymakers and take your industry pursuits to the next level. Secure your tickets now before the event sells out!

Czech Health Minister: ‘We Are Waiting For Germany To Legalize Cannabis’

One of the most active places on the planet right now for cannabis reform discussions is the Czech Republic. If you have followed our previous coverage, then you know that there is a strong push underway in the Czech Republic to legalize cannabis for adult use.

In October 2022 the national anti-drug coordinator for the Czech Republic, Jindřich Vobořil, announced his plan to pursue adult-use legalization.

“At the moment, there is a political consensus for me to create this proposal for the regulation of cannabis, a substance which is illegal at the moment. We want to regulate it with the help of the market and we believe that this regulation will be more effective than the current ban.” Jindřich Vobořil stated at the time.

Mere days after Germany’s Health Minister Karl Lauterbach held a historic press conference in Germany to provide an update about his nation’s legalization plans, news broke in the Czech Republic about some of the facets that may eventually make it into Czech law.

The model that made headlines back then (April 2023) involves the Czech Republic legalizing adult-use cannabis production and sales under a tightly regulated system. Consumers would be able to purchase up to five grams of cannabis per day according to domestic reporting, and consumers would be required to sign up through a government tracking database.

Meanwhile, running parallel to the reform push was the prosecution in the Czech Republic of a cannabis educator and journalist named Robert Veverka. Robert Veverka is the director of the Czech-based cannabis magazine LegalizaceBack in October 2021, we published an article about Robert being targeted by the Czech government over his journalism, with the government accusing him of “inciting and promoting toxicomania.”

Unfortunately, the Czech Republic proceeded with the indictment and in November 2021 Veverka and his media outlet were found guilty of the allegations, and Veverka was given a one-year prison sentence contingent on a probationary period of two and a half years as well as a fine of 50,000 CZK by the district court in Bruntál following two court hearings.

“The judge mentioned that he is not competent to assess the benefits of the current legislation, the benefits of cannabis products in healthcare, or the negative effects of cannabis use, but that he must base his verdict on the existing legislation which is binding for all. He stated that according to his judgement, Legalizace magazine evidently and factually constituted the criminal offence of inciting and promoting toxicomania.” Veverka stated at the time of the November 2021 verdict in a press release.

“He did not take into account the legislative provisions allowing for cannabis to be handled legally in certain cases or the comprehensive and educational nature of the information published in the magazine. On the contrary, the judge expressed his doubts as to whether the individuals who granted interviews to the magazine were made aware of its content and overall message. Personally, I consider the verdict to be very biased and severely restrictive of the freedom of expression, the right to express political opinion, and the right to information,” Veverka also stated.

Veverka must reportedly pay an administrative offense of €4.000 (as a defendant and a natural person) and €6.000 on behalf of his media outlet as part of an additional recent verdict. For anyone that is able to support Robert Veverka and contribute to his defense, bank details are below. If you are not able to contribute financially, please help spread the word on your social channels about his plight:

IBAN: CZ4320100000002900469065
BIC/SWIFT: FIOBCZPPXXX
Fio banka, as, V Celnici 1028/10, 117 21 Praha 1

This month the cannabis reform discussion in the Czech Republic took yet another turn, with the nation’s health minister offering up a series of comments about the nation’s push to legalize cannabis for adult use.

Minister Vlastimil Válek’s comments seemed to fail to accurately describe where things are currently at in Germany regarding cannabis reform, particularly as it pertained to Germany’s discussions with the European Union. Per ZdraveZpravy.cz:

Nevertheless, Minister Válek expressed his opinion regarding the actual approval of the standard, which would open up the market for cannabis containing a high amount of the psychoactive substance THC from January next year. He said that he is waiting for his colleagues from Germany, who are also trying to take a similar step. However, they are worried about how the European Commission [EC] and other EU member states, which oppose cannabis, would accept the legalization of cannabis in Germany. At stake are impacts on the EU-wide legal and illegal cannabis trade and market. It is exactly this, along with other questions, that the Germans are dealing with with EC representatives.

“I’m waiting for colleagues from Germany who are trying something similar. And they are not at the stage yet, and they promised us that they will show us the draft of the law, which of course the EC must give a positive opinion on, because it will be a certain breakthrough in what is in Europe,” Minister Válek explained to ZdraveZpravy.cz.

For starters, Minister Válek’s comments seem to passively disregard the fact that Malta has already passed an adult-use legalization measure and that regional adult-use cannabis commerce pilot programs also are already in existence in Europe (albeit in a limited-scope fashion).

To be fair, legalization in Germany would presumably be performed on a much larger scale than what is going on in Malta and with pilot programs in places such as Basel, Switzerland. However, the basic principle of the European Union and member states dealing with modernized cannabis policies in some form in some nations is not a new thing. The ‘what will Europe do if laws are reformed?’ talking point died a while ago, and it’s obviously time for cannabis opponents to move on.

German Health Minister Lauterbach made it clear in his April 2023 press conference that while the European Union would not permit nationwide sales to anyone of legal age, many of the components of Minister Lauterbach’s legalization did appear to receive approval, or at least that the European Union would not stand in the way of them.

While there is nearly no way to know if Minister Lauterbach has personally sent a copy of the current version of Germany’s legalization plan to his counterpart in the Czech Republic, there is still a considerable amount of information out in the public regarding where things currently stand and what is involved, and that the legalization plan is currently working its way around political circles in Germany.

For Minister Válek to act so clueless about where things are at in Germany seems disingenuous to me, however, that is not uncommon in politics. Ultimately, as things move along in Germany the pressure will build in the Czech Republic and many other parts of Europe, and many of the talking points that are being thrown around right now will fizzle.

Fewer Incidents Between Youth And Police Following Canadian Legalization

An area of top concern for both cannabis supporters and opponents alike is youth safety. Of course, what motivates each side’s concerns, the talking points used, and the predictions of what the future holds in a post-reform world differ greatly between the two sides, but at the most basic level, everyone should agree that youth safety is important.

Arguably the most popular talking point for cannabis opponents is that, so they claim, if cannabis is legalized for adult use then there will be a spike in youth consumption at levels never seen before in human history, and the consequences of such will be nothing short of catastrophic.

Unfortunately for those opponents, and fortunately for the rest of us that live in reality, such spikes in youth consumption have yet to materialize where cannabis has been legalized. Furthermore, in Canada specifically, there have been fewer recorded incidents between youth and law enforcement following national legalization. Below is more information about it via a news release from NORML:

Toronto, Canada: The legalization of the adult-use marijuana market is associated with reduced incidents between police and juveniles, according to data published in the journal Drug and Alcohol Dependence.

Researchers affiliated with the Centre for Addiction and Mental Health in Toronto analyzed police-reported incident data from the years immediately prior to and following the adoption of cannabis legalization in Canada.

They reported that legalization “was associated with significant reductions in both male and female police-reported cannabis-related offenses” for youth ages 12 to 17. (Canadian law permits those age 18 and older to legally possess and use cannabis products.) They estimated that these reductions have led to approximately 21,000 fewer criminal interactions between police and young people in the years following nationwide legalization.

The study’s authors concluded: “The Cannabis Act was associated with sustained and substantial decreases of approximately 50 percent to 60 percent in national patterns of male and female police-reported youth cannabis-related criminal incidents over an approximate three-year post-legalization period.… Given that involvement with the police and Canadian criminal justice system for cannabis-related criminal incidents represents a major social and individual-level harm for young people, it is reasonable to conclude that our findings demonstrate a benefit associated with the implementation of the Cannabis Act.”

Full text of the study, “Canada’s cannabis legalization and police-reported cannabis-related criminal incidents among youth, 2015-2020,” appears in Drug and Alcohol Dependence.

Hemp Leaves No Longer A Novel Food Under EU Law

Cannabinoid-based products are increasing in popularity across the globe, and particularly so in Europe. ‘Cannabis light’ products are widely available in Europe, although they are not always completely legal.

Part of the problem is the patchwork of laws, rules, and regulations in Europe, with individual countries often having their own set of policies, with the European Union having sometimes conflicting policies. What is legal in one country may not be legal in another country, and all of it may be illegal in the eyes of the European Union depending on the situation.

To further complicate things, hemp and cannabis are treated differently by the governments of Europe (and elsewhere on earth), even though they are ultimately the same plant. If the THC content of a plant is under a threshold, typically .3-1%, then it is hemp. If it is above the threshold, then it is cannabis according to various governments.

It may seem like a big game of semantics to some, however, when it comes to public policy in Europe and the emerging industries that are governed by such policies, words matter. Thankfully, there is now reportedly clarification for hemp leaves at the European Union level, with the EU recently indicating that hemp leaves are no longer considered to be a ‘Novel Food.’ Per Cannabis Health News:

Hemp leaves, when separate from the flower, are now no longer classed as a Novel Food under EU law, permitting the sale of hemp-infused tea and tea-like products in member states.

An agreement to modify the Novel Food Catalogue was reached by EU members as part of a European Commission (EC) working group on Friday 2 June.

It’s now over four years since the EC made the controversial decision to classify all parts of the plants as Novel, meaning companies would need to apply for Novel Food status in order to legally sell cannabinoid-based products containing less than 0.3% THC in the EU.

The recent decision is obviously significant for people that sell cannabis teas and other products derived from hemp leaves. However, the decision clearly does not go far enough, and anything that is not derived from hemp leaves still faces a considerable amount of bureaucratic hurdles.

Europe’s emerging cannabis industry is increasing in size despite the playing field being far from level for cannabis companies compared to companies in many other major industries. Hopefully the governments of Europe, and the European Union itself, moves faster to modernize the continent’s cannabis policies.

German Health Minister Sees Legalization’s Success In Canada Firsthand

Arguably the most popular person in the international cannabis scene right now, for better or worse, is German Health Minister Karl Lauterbach. Minister Lauterbach made international headlines in October 2022 when he presented a plan to Germany’s federal cabinet and has served as a primary focus of international cannabis observers like myself ever since.

For several months cannabis advocates watched Minister Lauterbach’s social media channels with a very close eye, and even some of his in-person appearances yielded speculation as to what it may mean for Germany’s legalization efforts. Now that Minister Lauterbach’s legalization plan is being circulated amongst lawmakers in Germany, the focus on him has lessened, however, it has not completely subsided.

That was on full display when Minister Lauterbach traveled days ago to Canada and met with Canada’s Minister for Mental Health and Addiction Dr. Bennett to discuss cannabis policy. What Minister Lauterbach witnessed with his own two eyes, legalization succeeding, was significant. Below is his tweet about it:

Auto-translating his tweet from German to English, the tweet stated: “Meeting today with Canadian Minister for Mental Health and Addiction Dr. Bennett on cannabis legalization. The doctor says legalization has not led to an increase in consumption there, not even among young people. 70% of the black market is gone.”

A lot of anti-cannabis rhetoric is being tossed around these days in Germany as the legalization push continues, and one of my biggest pet peeves is cannabis opponents acting as if Canada didn’t legalize cannabis for adult use at the national level in 2018, and that there is not a significant amount of data available as a result. Unfortunately for those opponents, the reality we all live in speaks for itself.

As Minister Lauterbach’s tweet points out, claims that cannabis consumption will spike post-legalization have not materialized in Canada, and it’s likely that any limited increase in reported use is more indicative of longtime consumers finally being willing to admit it to government data collectors.

Furthermore, youth consumption, which cannabis opponents seem to constantly try to make the focus of their fear-mongering propaganda efforts. has not increased post-legalization in Canada, and that’s per Canada’s Minister for Mental Health and Addiction.

Cannabis opponents will cling to the out-of-context talking point that the unregulated market still exists in Canada, however, knowing that 70% of cannabis sales have transitioned to the regulated market is obviously meaningful. That’s a massive amount of revenue that used to go to organized crime and now goes toward boosting Canada’s economy, including to funding projects that benefit non-cannabis consumers.

Legalization works. It is working in Canada, and it will also work in Germany and wherever else lawmakers modernize their jurisdiction’s cannabis policies in a sensible way.

Cannabis Opponents Spread Misinformation In Slovenia

Earlier this month cannabis opponents in Slovenia provided an open letter to European Commissioner for Home Affairs Ylva Johansson. The cannabis opponents also issued a press release, which is common for anti-cannabis propaganda efforts. The letter was sent by Preventivna Platforma, which describes itself as ‘a network of NGOs that work in the field of prevention.’ The entity’s professed overall goal is ‘quality in prevention’ and they tout in their publications that their efforts ‘receive financial assistance from Slovenia’s Ministry of Health.’

Preventivna Platforma’s letter was geared towards encouraging Commissioner Johansson to join them in opposing adult-use legalization in Germany. To someone that is not familiar with prohibitionist talking points, the letter may seem scary. However, as any long-time cannabis advocate will quickly point out, the letter is riddled with half-truths, lack of context, and in some cases, claims that are not supported by evidence and reality.

“As non-governmental organizations that work in the field of prevention, treatment, rehabilitation and recovery from drug use and addiction, we strongly oppose the legalization of cannabis. We are convinced that it will increase cannabis use and harm in Germany, and will also undermine the efforts of other EU member states in the field of preventing drug use and related harm.” the letter stated (translated from Slovenian to English.

As is often the case with anti-cannabis propaganda, the letter from Preventivna Platforma makes general claims that are easily refuted with peer-reviewed studies, logical reasoning, and government data from legal jurisdictions. For many years, opponents could make such claims and never be challenged because, after all, there were no legal jurisdictions to point to. That is obviously no longer the case.

We now know what happens when jurisdictions legalize cannabis for adult use; that the sky does not fall, and that the success of legalization in legal jurisdictions is likely why Preventivna Platforma relied so heavily on technical legal arguments in their letter rather than making a case that cannabis prohibition is better public policy than modernized regulation.

“Plans to legalize cannabis in Germany run counter to international drug control conventions, which have been ratified by all EU member states, among others. The International Narcotics Control Board (INCB) has repeatedly criticized similar policies in the United States, Canada and Uruguay.” Preventivna Platforma stated in its letter.

“By legalizing cannabis, Germany would also violate the sixth chapter of the Schengen Agreement, which stipulates that EU member states must respect the UN conventions on the control of illegal drugs and take the necessary measures to prevent illegal traffic in them. In addition, the German plans conflict with the EU Council Framework Decision 2004/757/RIF, which states that EU member states must ensure that the production, acquisition, sale, distribution, marketing, transportation and importation of illicit drugs, including cannabis, a felony.” the letter goes on to say.

Preventivna Platforma states in its letter that, “the German government wants to open up a legal, commercial market for cannabis, something that has not yet happened in any EU member state.” Obviously, there are two countries that have already legalized a cannabis commercial market at a national level, albeit not in Europe, and Preventivna Platforma omitting that fact seems to be purposeful. Cannabis opponents will always try to deflect and distract from legalization succeeding in other places.

A classic cannabis prohibitionist talking point that was incorporated by Preventivna Platforma in its letter ironically makes a strong argument for widespread legalization, which is the only true way to prevent diversion from regulated markets to unregulated markets.

“Undoubtedly, the legalization of cannabis in Germany would have a significant impact at least on neighboring countries. In a single market with open borders, it would be difficult to ensure that hemp grown legally in Germany does not divert to more profitable markets in other countries. Indeed, experience from the United States of America confirms that there is a high risk of diversion of cannabis from legal to illegal markets in other areas where its sale is not allowed.” the open letter states.

The letter goes on to cherry-pick certain information while ignoring other available information that either directly refutes their claims or puts it into proper context.

“After a decade, the legalization of cannabis in the countries where it has been legalized so far is still relatively in its infancy, but the first findings worry us. Data from the US show that cannabis consumption has increased, particularly more intensive use. Canadian data is scarcer, but official statistics show that both regular and frequent cannabis users have increased in the years since legalization.” Preventivna Platforma stated.

For starters, adults consuming more cannabis is not automatically a bad thing, and studies are showing that cannabis is often used as a substitute for more harmful substances, which is clearly a great thing. There seems to never be controls in the collection process of government usage data to calculate for long-time cannabis consumers finally admitting to government data collectors that they consume cannabis.

Government data collectors will record those people as being ‘new users’ when that is not actually the case. Speaking from firsthand experience, there was no way that I was ever going to tell the government that I consumed a product that was prohibited, and it’s logical to assume that I am far from alone in changing my answer after my jurisdiction’s (Oregon) cannabis policies were modernized. People need to keep that in mind when there are ‘rising consumption rates’ reported post-legalization.

Furthermore, and the propaganda letter tries to make it seem as if the two are connected, while adult use may be increasing in legal jurisdictions, the same is not true for kids and young people. It’s a ‘three card monte’ maneuver that prohibitions use because they assume that most people won’t unpack their talking points and that people will assume that if consumption rates are going up, then clearly that extends to young people. But as we know from data out of Canada, which is not ‘scarcer’ despite what prohibitionists claim, as well as data out of the United States, a spike in youth consumption post-legalization has yet to materialize.

Per government data from the Oregon Health Authority, not only was there no spike in youth consumption following the launch of legal adult-use sales and outright possession legalization in 2015; youth consumption rates actually went down from 2012 to 2018 in Oregon. A broader study conducted by researchers at Michigan State University, which involved consumption survey data from over 800,000 respondents in states where cannabis sales were permitted, also found no spike in youth cannabis usage rates.

A study in 2021 conducted by researchers in Canada found ‘no significant differences’ in cannabis consumption rates before and after cannabis legalization in Canada. As of May 2022, data out of Uruguay also demonstrated no sustained changes in youth consumption rates post-legalization.

Another popular prohibitionist talking point that does not provide nearly enough context is that ‘the unregulated cannabis market still exists in Canada and the United States.’

“One of the main goals of legalization was to eliminate the illegal cannabis market. However, there is still a thriving illegal market in all jurisdictions, supplying both the local market and markets in neighboring countries.” Preventivna Platforma stated.

Make no mistake about it, the unregulated cannabis market will always exist, just as the unregulated tobacco and alcohol markets will always exist, and the market for fake apparel and bootlegged entertainment media will always exist. Just because an unregulated market exists to some small degree does not in any way justify prohibition and the economic and social costs that go with it. The goal is to mitigate the unregulated market as much as reasonably possible for various reasons, not the least of which are improving public health outcomes via boosting regulated product availability, and taking money out of the hands of organized crime.

One talking point that is seemingly always included in anti-cannabis propaganda is the ‘terror on the roadways’ talking point.

“The increase in use is accompanied, among other things, by an increase in the number of traffic accidents and accompanying deaths related to cannabis, an increase in the number of visits to emergency centers and hospitalizations…” the letter stated.

However, a study from this month out of Canada found that, per the researchers, “[N]either the CCA [Canadian Cannabis Act] nor the NCS [number of cannabis stores per capita] is associated with concomitant changes in (traffic safety) outcomes. … During the first year of the CRUL’s [cannabis recreational use laws] implementation in Toronto, no significant changes in crashes, number of road victims and KSI [all road users killed or severely injured] were observed.”

The Preventivna Platforma letter goes on to indicate that there is still a lot that is “unknown” when it comes to legalization and that the “consequences” of cannabis hyperemesis syndrome (CHS), which is an extremely rare condition, were “not known until a few years ago.” That claim was made despite the condition being mentioned in a study nearly twenty years ago.

Also, a study from this month out of the legal state of Massachusetts in the U.S. found that CHS only represented .1% of all hospitalizations in 2021. It’s a serious thing that sufferers need to be mindful of, however, it’s far from being an epidemic and the most common treatment for CHS is a warm shower and refraining from consuming cannabis. Furthermore, it’s entirely possible that the current rates for CHS in legal jurisdictions were always what is being reported now, but that people were too afraid to seek out medical advice pre-legalization due to fear of prosecution.

One citation that stood out to me in the letter was applied to the claim that THC vaping is responsible for “an epidemic of serious lung disease.” However, upon further examination, the citation is from the United States Centers for Disease Control’s (CDC) tobacco overview page. The CDC points out on that page that it is not regulated products that are responsible for suspected lung issues, but rather, the unregulated market, and it is classified as an “outbreak” and not an “epidemic.”

“National and state data from patient reports and product sample testing show tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, products, particularly from informal sources like friends, family, or in-person or online dealers, are linked to most EVALI cases and play a major role in the outbreak.” the CDC states on the page that is cited in the Slovenian anti-cannabis propaganda letter.

“Vitamin E acetate is strongly linked to the EVALI outbreak. Vitamin E acetate has been found in product samples tested by FDA and state laboratories and in patient lung fluid samples tested by CDC from geographically diverse states. Vitamin E acetate has not been found in the lung fluid of people that do not have EVALI.” the page goes on to say, which directly refutes the claim in the propaganda letter that THC from regulated products is the culprit for issues.

Again, the cannabis prohibitionists responsible for the recent letter make no genuine effort to argue that cannabis prohibition is an effective policy. Rather, they offer up half-truths, lack of context, and in some cases outright inaccurate information. Much like cannabis prohibitionists found elsewhere in the world, such as Kevin Sabet, they do anything they can to slow down the modernization of cannabis policies because, presumably, they know that the status quo is on their side, and they don’t have to move any needles.

All cannabis opponents must do is muck up the process and try to confuse as many people as possible, and they know it. They presumably believe that doing so will prevent meaningful reform from occurring, and that comes at the expense of having a rational conversation about cannabis policy in Slovenia, Europe, and anywhere else where these types of cannabis propaganda spreaders operate. Hopefully the citizens of Slovenia and European Commissioner for Home Affairs Ylva Johansson will see through the propaganda, and support Slovenia modernizing its cannabis policies for the sake of improved public health outcomes, as well as for the increased economic opportunities that sensible cannabis policies create.

Medical Cannabis Pilot Project Proposed In Iceland

The concept of cannabis commerce pilot projects is not a new thing and is seemingly growing in popularity among policymakers and regulators in Europe. The latest example of that can be found in Iceland, where a proposal was recently submitted to launch a medical cannabis-focused pilot project.

For those that may be unfamiliar with cannabis commerce pilot projects, medical and adult-use cannabis commerce projects allow jurisdictions to permit limited, legal cannabis commerce. The theory behind the concept is that it affords policymakers and regulators the opportunity to see how commerce works on a limited scale to be better suited to craft national policies.

Denmark currently has a medical-focused pilot program, and adult-use pilot programs are popping up in Switzerland. According to the current legalization plan in Germany, pilot programs will be part of the second phase of legalization once the details are figured out.

Iceland’s pilot project is somewhat different than what is going on in Switzerland, and eventually Germany, beyond just Iceland’s proposal being for medical versus adult use. One could easily argue that the proposal in Iceland is essentially an expansion of the nation’s medical cannabis program, albeit in a limited-duration fashion. Per Cannabis Health News:

Following a debate in Alþingi [Icelandic parliament] last week, officials have proposed a four-year pilot project to permit the use of medical cannabis, as well as the cultivation, production and distribution of cannabis-based products for medicinal use.

If approved, the Ministry of Health will work with the Minister of Culture and Trade to establish a working group to prepare a bill allowing companies to apply for licences to produce and distribute cannabis medicines.

The bill would need to be presented by the ministry by 31st December with the four-year pilot programme expected to begin on 1 January, 2024.

Currently, only the pharmaceutical product Sativex is available to suffering patients in Iceland, and even then, only in limited circumstances. Just as is the case everywhere around the globe, suffering patients in Iceland deserve to have safe, legal access to their medicine in whatever form helps them the best.

Only time will tell if the proposal in Iceland makes it to the finish line this year, and even if it does, whether or not 2024 will end up being the actual launch year. Pilot projects are notorious for experiencing delayed implementations. Hopefully that doesn’t prove to be the case in Iceland.